Zobrazeno 1 - 10 of 199 pro vyhledávání: '"Shahswar R"'
1
Akademický článek
Relapse and resistance in acute myeloid leukemia post venetoclax: improving second lines therapy and combinations.
Autor: Shahswar R; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Ganser A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Publikováno v: Expert review of hematology [Expert Rev Hematol] 2024 Oct; Vol. 17 (10), pp. 723-739. Date of Electronic Publication: 2024 Sep 13.
Zobrazit plný text záznamu
2
Akademický článek
Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Autor: Shahswar R; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Beutel G; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Gabdoulline R; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Schwarzer A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Kloos A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Koenecke C; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Stadler M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Gohring G; Department of Human Genetics, Hannover Medical School, Hannover., Behrens YL; Department of Human Genetics, Hannover Medical School, Hannover., Li Z; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Dallmann LK; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Klement P; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Albert C; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Wichmann M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Alwie Y; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Benner A; DKFZ German Cancer Research Center, Heidelberg., Saadati M; Saadati Solutions, Ladenburg., Ganser A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Thol F; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Heuser M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover. heuser.michael@mh-hannover.de.
Publikováno v: Haematologica [Haematologica] 2024 Jan 01; Vol. 109 (1), pp. 72-83. Date of Electronic Publication: 2024 Jan 01.
Zobrazit plný text záznamu
3
Akademický článek
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.
Autor: Waclawiczek A; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany., Leppä AM; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Renders S; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Stumpf K; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany., Reyneri C; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany., Betz B; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany., Janssen M; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Shahswar R; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Donato E; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany., Karpova D; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri., Thiel V; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Unglaub JM; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Grabowski S; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Gryzik S; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; MVZ Hämatologische Diagnostik, Heppenheim, Germany., Vierbaum L; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Schlenk RF; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; NCT Trial Center, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany., Röllig C; Medizinische Klinik und Poliklinik I, Universitätsklinikum der Technischen Universität Dresden, Dresden, Germany., Hundemer M; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; MVZ Hämatologische Diagnostik, Heppenheim, Germany., Pabst C; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; Comprehensive Cancer Center Niedersachsen, Hannover, Germany., Raffel S; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Müller-Tidow C; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; Molecular Medicine Partnership Unit EMBL-UKHD, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Sauer T; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Trumpp A; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.
Publikováno v: Cancer discovery [Cancer Discov] 2023 Jun 02; Vol. 13 (6), pp. 1408-1427.
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia.
Autor: Walter W; MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany. wencke.walter@mll.com., Shahswar R; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, 30625, Hannover, Germany., Stengel A; MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany., Meggendorfer M; MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany., Kern W; MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany., Haferlach C; MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany.
Publikováno v: BMC cancer [BMC Cancer] 2021 Aug 02; Vol. 21 (1), pp. 886. Date of Electronic Publication: 2021 Aug 02.
Zobrazit plný text záznamu
8
Report
Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q.
Autor: Panagiota V; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany., Kubasch AS; Department of Hematology and Cell Therapy, Medical Clinic and Policlinic I, Leipzig University Hospital, Leipzig, Germany., Gabdoulline R; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Krönke J; Department of Internal Medicine III, University Hospital Medical Center, Ulm, Germany., Mies A; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Shahswar R; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Kandziora C; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Klement P; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Schiller J; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Göhring G; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany., Ganster C; Department of Hematology and Oncology, Georg-August-Universität-Göttingen, Göttingen, Germany., Shirneshan K; Department of Hematology and Oncology, Georg-August-Universität-Göttingen, Göttingen, Germany., Gutermuth A; Department of Hematology and Oncology, Georg-August-Universität-Göttingen, Göttingen, Germany., Thiede C; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Germing U; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany., Schroeder T; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany., Kobbe G; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany., Klesse S; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Koenecke C; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Schlegelberger B; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Haase D; Department of Hematology and Oncology, Georg-August-Universität-Göttingen, Göttingen, Germany., Döhner K; Department of Internal Medicine III, University Hospital Medical Center, Ulm, Germany., Sperr WR; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Valent P; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Platzbecker U; Department of Hematology and Cell Therapy, Medical Clinic and Policlinic I, Leipzig University Hospital, Leipzig, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Publikováno v: American journal of hematology [Am J Hematol] 2021 Jun 01; Vol. 96 (6), pp. E207-E210. Date of Electronic Publication: 2021 Apr 07.
Zobrazit plný text záznamu
9
Akademický článek
Membrane Antigen Targeting in Acute Myeloid Leukemia Using Antibodies or CAR-T Cells.
Autor: Testa, Ugo1 (AUTHOR) germana.castelli@iss.it, Castelli, Germana1 (AUTHOR), Pelosi, Elvira1 (AUTHOR)
Publikováno v: Cancers. Nov2024, Vol. 16 Issue 21, p3627. 29p.
Zobrazit plný text záznamu
10
Akademický článek
Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen—Single-Center Analysis.
Autor: Machherndl-Spandl, Sigrid1,2 (AUTHOR) alexander.nikoloudis@ordensklinikum.at, Hannouf, Sarah1,2 (AUTHOR) irene.strassl@ordensklinikum.at, Nikoloudis, Alexander1,2 (AUTHOR) emine.kaynak@ordensklinikum.at, Zach, Otto3 (AUTHOR) otto.zach@ordensklinikum.at, Strassl, Irene1,2 (AUTHOR) holger.rumpold@ordensklinikum.at, Kaynak, Emine1 (AUTHOR) veronika.buxhofer-ausch@ordensklinikum.at, Webersinke, Gerald3 (AUTHOR) gerald.webersinke@ordensklinikum.at, Gruber-Rossipal, Christine4 (AUTHOR) christine.gruber-rossipal@pathologieverbund.at, Rumpold, Holger1,2 (AUTHOR), Schimetta, Wolfgang5 (AUTHOR) wolfgang.schimetta@asoklif.at, Clausen, Johannes1,2 (AUTHOR) sigrid.machherndl-spandl@ordensklinikum.at, Buxhofer-Ausch, Veronika1,2 (AUTHOR)
Publikováno v: Cancers. Oct2024, Vol. 16 Issue 19, p3257. 16p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje